AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individuals
Authors: Veldkamp, AI van Heeswijk, RPG Mulder, JW Meenhorst, PL Schreij, G van der Geest, S Lange, JMA Beijnen, JH Hoetelmans, RMW
Citation: Ai. Veldkamp et al., Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individuals, J ACQ IMM D, 27(4), 2001, pp. 344-349
A retrospective, cohort-based survey of patients using twice-daily indinavir plus ritonavir combinations: Pharmacokinetics, safety, and efficacy
Authors: Burger, DM Hugen, PWH Aarnoutse, RE Dieleman, JP Prins, JM van der Poll, T ten Veen, JH Mulder, JW Meenhorst, PL Blok, WL van der Meer, JTM Reiss, P Lange, JMA
Citation: Dm. Burger et al., A retrospective, cohort-based survey of patients using twice-daily indinavir plus ritonavir combinations: Pharmacokinetics, safety, and efficacy, J ACQ IMM D, 26(3), 2001, pp. 218-224
The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV-1-infected individuals
Authors: Koks, CHW Crommentuyn, KML Hoetelmans, RMW Burger, DM Koopmans, PP Mathot, RAA Mulder, JW Meenhorst, PL Beijnen, JH
Citation: Chw. Koks et al., The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV-1-infected individuals, BR J CL PH, 51(6), 2001, pp. 631-635
Drug interaction between St John's wort and nevirapine
Authors: de Maat, MMR Hoetelmans, RMW Mathot, RAA van Gorp, ECM Meenhorst, PL Mulder, JW Beijnen, JH
Citation: Mmr. De Maat et al., Drug interaction between St John's wort and nevirapine, AIDS, 15(3), 2001, pp. 420-421
Limited sampling strategies for the estimation of the systemic exposure tothe HIV-1 nonnucleoside reverse transcriptase inhibitor nevirapine
Authors: Veldkamp, AI van Heeswijk, RPG Mulder, JW Meenhorst, PL Hoetelmans, RMW Lange, JMA Beijnen, JH
Citation: Ai. Veldkamp et al., Limited sampling strategies for the estimation of the systemic exposure tothe HIV-1 nonnucleoside reverse transcriptase inhibitor nevirapine, THER DRUG M, 23(6), 2001, pp. 606-611
Saliva as an alternative body fluid for therapeutic drug monitoring of thenonnucleoside reverse transcription inhibitor nevirapine
Authors: van Heeswijk, RPG Veldkamp, AI Mulder, JW Meenhorst, PL Beijnen, JH Lange, JMA Hoetelmans, RMW
Citation: Rpg. Van Heeswijk et al., Saliva as an alternative body fluid for therapeutic drug monitoring of thenonnucleoside reverse transcription inhibitor nevirapine, THER DRUG M, 23(3), 2001, pp. 255-258
Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study
Authors: Nieuwkerk, PT Sprangers, MAG Burger, DM Hoetelmans, RMW Hugen, PWH Danner, SA van der Ende, ME Schneider, MME Schrey, G Meenhorst, PL Sprenger, HG Kauffmann, RH Jambroes, M Chesney, MA de Wolf, F Lange, JMA
Citation: Pt. Nieuwkerk et al., Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study, ARCH IN MED, 161(16), 2001, pp. 1962-1968
Nevirapine plus didanosine: Once or twice daily combination?
Authors: van Heeswijk, RPG Veldkamp, AI Mulder, JW Meenhorst, PL Wit, FWNM Reiss, P Lange, JMA Kwakkelstein, MO Beijnen, JH Hoetelmans, RMW
Citation: Rpg. Van Heeswijk et al., Nevirapine plus didanosine: Once or twice daily combination?, J ACQ IMM D, 25(1), 2000, pp. 93-95
Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study
Authors: van Heeswijk, RPG Veldkamp, AI Mulder, JW Meenhorst, PL Lange, JMA Beijnen, JH Hoetelmans, RMW
Citation: Rpg. Van Heeswijk et al., Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study, AIDS, 14(9), 2000, pp. F103-F110
The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals
Authors: van Heeswijk, RPG Veldkamp, AI Mulder, JW Meenhorst, PL Wit, FWNM Lange, JMA Danner, SA Foudraine, NA Kwakkelstein, MO Reiss, P Beijnen, JH Hoetelmans, RMW
Citation: Rpg. Van Heeswijk et al., The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals, AIDS, 14(8), 2000, pp. F77-F82
Itraconazole as an alternative for ritonavir liquid formulation when combined with saquinavir
Authors: Koks, CHW van Heeswijk, RPG Veldkamp, AI Meenhorst, PL Mulder, JW van der Meer, JTM Beijnen, JH Hoetelmans, RMW
Citation: Chw. Koks et al., Itraconazole as an alternative for ritonavir liquid formulation when combined with saquinavir, AIDS, 14(1), 2000, pp. 89-90
Saliva as a specimen for monitoring compliance but not for predicting plasma concentrations in patients with HIV treated with indinavir
Authors: Hugen, PWH Burger, DM de Graaff, M ter Hofstede, HJM Hoetelmans, RMW Brinkman, K Meenhorst, PL Mulder, JW Koopmans, PP Hekster, YA
Citation: Pwh. Hugen et al., Saliva as a specimen for monitoring compliance but not for predicting plasma concentrations in patients with HIV treated with indinavir, THER DRUG M, 22(4), 2000, pp. 437-445
Value of different assays for detection of human cytomegalovirus (HCMV) inpredicting the development of HCMV disease in human immunodeficiency virus-infected patients
Authors: Blank, BSN Meenhorst, PL Mulder, JW Weverling, GJ Putter, H Pauw, W van Dijk, WC Smits, P Lie-A-Ling, S Reiss, P Lange, JMA
Citation: Bsn. Blank et al., Value of different assays for detection of human cytomegalovirus (HCMV) inpredicting the development of HCMV disease in human immunodeficiency virus-infected patients, J CLIN MICR, 38(2), 2000, pp. 563-569
Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection
Authors: Veldkamp, AI van Heeswijk, RPG Meenhorst, PL Mulder, JW Lange, JMA Beijnen, JH Hoetelmans, RMW
Citation: Ai. Veldkamp et al., Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection, J CHROMAT B, 734(1), 1999, pp. 55-61
Rapid quantification of delavirdine, a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with fluorescence detection
Authors: Veldkamp, AI van Heeswijk, RPG Hoetelmans, RMW Meenhorst, PL Mulder, JW Lange, JMA Beijnen, JH
Citation: Ai. Veldkamp et al., Rapid quantification of delavirdine, a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with fluorescence detection, J CHROMAT B, 727(1-2), 1999, pp. 151-157
Ritonavir enables combined therapy with rifampin and saquinavir
Authors: Veldkamp, AI Hoetelmans, RMW Beijnen, JH Mulder, JW Meenhorst, PL
Citation: Ai. Veldkamp et al., Ritonavir enables combined therapy with rifampin and saquinavir, CLIN INF D, 29(6), 1999, pp. 1586-1586
Follow-up of ecstasy intoxication
Authors: Beijnen, JH Meenhorst, PL
Citation: Jh. Beijnen et Pl. Meenhorst, Follow-up of ecstasy intoxication, J TOX-CLIN, 37(3), 1999, pp. 343-343
Paclitaxel in the treatment of human immunodeficiency virus 1-associated Kaposi's sarcoma - drug-drug interactions with protease inhibitors and a nonnucleoside reverse transcriptase inhibitor: a case report study
Authors: Panday, VRN Hoetelmans, RMW van Heeswijk, RPG Meenhorst, PL Inghels, M Mulder, JW Beijnen, JH
Citation: Vrn. Panday et al., Paclitaxel in the treatment of human immunodeficiency virus 1-associated Kaposi's sarcoma - drug-drug interactions with protease inhibitors and a nonnucleoside reverse transcriptase inhibitor: a case report study, CANC CHEMOT, 43(6), 1999, pp. 516-519
Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study)
Authors: Stuart, JWTC Schuurman, R Burger, DM Koopmans, PP Sprengers, HG Juttmann, JR Richter, C Meenhorst, PL Hoetelmans, RMW Kroon, FP Bravenboer, B Hamann, D Boucher, CAB Borleffs, JCC
Citation: Jwtc. Stuart et al., Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study), AIDS, 13(7), 1999, pp. F53-F58
Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients
Authors: Foudraine, NA Hovenkamp, E Notermans, DW Meenhorst, PL Klein, MR Lange, JMA Miedema, F Reiss, P
Citation: Na. Foudraine et al., Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients, AIDS, 13(2), 1999, pp. 177-184
Quantitative pp65-antigenemia assay for the prediction of human cytomegalovirus disease in HIV-infected patients
Authors: Blank, BSN Meenhorst, PL Weverling, GJ Stout-Zonneveld, AAM Pauw, W Mulder, JW van Dijk, WC Smits, P Lange, JMA
Citation: Bsn. Blank et al., Quantitative pp65-antigenemia assay for the prediction of human cytomegalovirus disease in HIV-infected patients, AIDS, 13(18), 1999, pp. 2533-2539
The steady-state plasma pharmacokinetics of indinavir alone and in combination with a low dose of ritonavir in twice daily dosing regimens in HIV-1-infected individuals
Authors: van Heeswijk, RPG Veldkamp, AI Hoetelmans, RMW Mulder, JW Schreij, G Hsu, A Lange, JMA Beijnen, JH Meenhorst, PL
Citation: Rpg. Van Heeswijk et al., The steady-state plasma pharmacokinetics of indinavir alone and in combination with a low dose of ritonavir in twice daily dosing regimens in HIV-1-infected individuals, AIDS, 13(14), 1999, pp. F95-F99
Monitoring of Epstein-Barr virus DNA load in peripheral blood by quantitative competitive PCR
Authors: Stevens, SJC Vervoort, MBHJ van den Brule, AJC Meenhorst, PL Meijer, CJLM Middeldorp, JM
Citation: Sjc. Stevens et al., Monitoring of Epstein-Barr virus DNA load in peripheral blood by quantitative competitive PCR, J CLIN MICR, 37(9), 1999, pp. 2852-2857
Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults
Authors: Notermans, DW Pakker, NG Hamann, D Foudraine, NA Kauffmann, RH Meenhorst, PL Goudsmit, J Roos, MTL Schellekens, PTA Miedema, F Danner, SA
Citation: Dw. Notermans et al., Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults, J INFEC DIS, 180(4), 1999, pp. 1050-1056
Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma byion-pair high-performance liquid chromatography with ultraviolet detection
Authors: van Heeswijk, RPG Hoetelmans, RMW Harms, R Meenhorst, PL Mulder, JW Lange, JMA Beijnen, JH
Citation: Rpg. Van Heeswijk et al., Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma byion-pair high-performance liquid chromatography with ultraviolet detection, J CHROMAT B, 719(1-2), 1998, pp. 159-168
Risultati: 1-25 | 26-27